445 related articles for article (PubMed ID: 11363599)
1. Progress report: prophylaxis and therapy for MAC.
Currier J
AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
[TBL] [Abstract][Full Text] [Related]
2. MAC management.
PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
[TBL] [Abstract][Full Text] [Related]
3. MAC prophylaxis revisited.
Torres G
GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706
[TBL] [Abstract][Full Text] [Related]
4. Advances in prevention and treatment of MAC.
Cheng B
PI Perspect; 1995 Dec; (no 17):11. PubMed ID: 11363104
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
7. Antivirals key to MAC prevention regimen.
AIDS Alert; 1996 Sep; 11(9):101-3. PubMed ID: 11363722
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
[TBL] [Abstract][Full Text] [Related]
10. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
Schouten JT; Whittemore S
STEP Perspect; 1996; 8(3):5-6. PubMed ID: 11364267
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
[TBL] [Abstract][Full Text] [Related]
12. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
[TBL] [Abstract][Full Text] [Related]
13. Another perspective on MAC prophylaxis. Interview by Gordon Nary.
Pierce M
J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):16-8. PubMed ID: 11362746
[TBL] [Abstract][Full Text] [Related]
14. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Uthman MM; Uthman OA; Yahaya I
Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Benson CA; Kessler HA; Pottage JC; Trenholme GM
Arch Intern Med; 1991 Mar; 151(3):582-5. PubMed ID: 2001140
[TBL] [Abstract][Full Text] [Related]
16. Disseminated MAC: current treatment strategies.
Ferreira T
STEP Perspect; 1995; 7(2):15-6. PubMed ID: 11362719
[TBL] [Abstract][Full Text] [Related]
17. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
19. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
Shafran SD; Deschênes J; Miller M; Phillips P; Toma E
N Engl J Med; 1994 Feb; 330(6):438-9. PubMed ID: 8284019
[No Abstract] [Full Text] [Related]
20. [Uveitis associated with rifabutin treatment. Apropos of 3 patients].
Chevalley GF; Kaiser L; Bouchenaki N; Baglivo E; Kress O
Klin Monbl Augenheilkd; 1995 May; 206(5):388-90. PubMed ID: 7609395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
